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Summary
Myocardial fibrosis (MF) that occurs in aortic stenosis
(AS) has been shown to be associated with a poor prog-
nostic outcome post surgical aortic valve replacement
(SAVR) but not in the high risk patients suitable for
Transcatheter aortic valve implantation (TAVI). Using
the technique of late-gadolinium enhancement we have
shown that MF regresses post-TAVI but not post-
SAVR, and that ejection fraction rather than MF is the
independent predictor of reverse remodeling.
Background
Myocardial Fibrosis (MF) occurs as part of the remodel-
ling process in left ventricular hypertrophy associated
with severe aortic stenosis (AS). MF has been shown to
be associated with reduced left ventricle (LV) ejection
fraction and poor prognosis following surgical aortic
valve replacement (SAVR). Transcatheter aortic valve
implantation (TAVI) has become a standard procedure
for the treatment of severe aortic stenosis in high risk
or inoperable patients. The significance of MF in this
high-risk patient population has to date not been
assessed. We aimed to assess the baseline burden of
MF, its change following TAVI and SAVR, and its influ-
ence on LV reverse remodeling.
Methods
Fifty high-risk patients (EuroSCORE ≥20) with severe
AS (peak velocity >4m/s) underwent TAVI (n=25) or
SAVR (n=25). Steady-state free procession short axis
(SA) cine imaging was performed to determine LV mass
and volumes. MF was assessed by late-gadolinium
enhancement (LGE) in 47 patients. A look-locker
sequence was performed 10 minutes following the
administration of 0.2mmol/kg of Gadoteric acid
(Doteram, Guerbet, SA, Villepinte). The inversion time
was individually adjusted and 10-12 short axis slices
(10mm thickness, matrix 240x240, typical FOV 340mm)
were acquired.
Results
MF was detected in 25 (53%) patients (TAVI 13(59%) vs.
SAVR 12(48%), P=0.38). Fibrosis was predominantly
found in the basal region and septal segments for both
groups. MF burden was greater in the TAVI group (10%
(35/352) of segments) compared to the SAVR group (5%
(19/400) segments), (P=0.01), Figure 1. Hypertension
was associated with an increased risk of baseline MF by
logistic regression (OR 5.9, P=0.015). Baseline MF bur-
den was positively associated with higher end-diastolic
(B 5.4, P<0.001), end-systolic (B 6.7, P<0.001) volumes,
greater mass (B 5.6, P=0.002) and negatively associated
with ejection fraction (B -3.9, P<0.001). MF predicted a
greater decrease in ESV (B -7.6, P<0.001) and increase
EF (B 1.8, P=0.008) post-TAVI and SAVR by univariate 1Multidisciplinary cardiovascular research, University of Leeds, Leeds, UK
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lysis as baseline EF was the dominant predictor of
improved EF (B-0.49, P<0.001). Fibrosis regressed post-
TAVI (35(10%) vs. 21(6%) segments, P=0.04) but not
post-SAVR (19(5%) vs. 16(4%) segments, P=0.32). TAVI
(OR 3.8, P=0.039) was associated with an increased like-
lihood of post-operative MF regression.
Conclusions
MF burden is associated with poor baseline LV volumes
and function. Baseline EF rather than MF independently
predicts reverse remodeling post TAVI and SAVR. Sig-
nificant regression of fibrosis occurred only post-TAVI.
This reduction of fibrosis may be important in improv-
ing prognosis following aortic valve replacement.
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Figure 1 Myocardial fibrosis burden (%) of the TAVI (A) and SAVR (B) patients, as represented on a segmental level according to the American
Heart Association 16 segment models. An example of the fibrosis in AS on late gadolinium enhancement is shown (C, white arrows).
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